Parkman Healthcare Partners’s Ambrx Biopharma Inc AMAM Stock Holding History

Parkman Healthcare Partners’s Portfolio AMAM Stock Details AMAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-87,678	Closed	-$1.25M	–	116
2023 Q4	$1.25M	Sell	87,678 -62,322	-42%	-$708K	0.18%	77
2023 Q3	$1.73M	Buy	+150,000	New	+$2.04M	0.32%	82
2021 Q3	–	Sell	-15,000	Closed	-$294K	–	87
2021 Q2	$294K	Buy	+15,000	New	+$256K	0.06%	80

Parkman Healthcare Partners's AMAM Position: Q1 2024 in Review

Parkman Healthcare Partners sold out of Ambrx Biopharma Inc (AMAM) in Q1 2024, closing a stake of 87,678 shares — an estimated $1.25M sold.

Parkman Healthcare Partners first reported a position in AMAM in Q2 2021 and held it in 3 quarters. The position peaked at $1.73M in Q3 2023. 0 funds tracked by Wall St. Rank hold AMAM as of Q1 2024.

Parkman Healthcare Partners reported no remaining Ambrx Biopharma Inc position as of Q1 2024 after selling out during the quarter.
Parkman Healthcare Partners sold 87,678 Ambrx Biopharma Inc shares in Q1 2024, an estimated $1.25M.
Parkman Healthcare Partners first reported a position in Ambrx Biopharma Inc in Q2 2021 and held it in 3 quarters.
Parkman Healthcare Partners's Ambrx Biopharma Inc position peaked at $1.73M in Q3 2023.
0 funds tracked by Wall St. Rank held Ambrx Biopharma Inc as of Q1 2024.

Based on Parkman Healthcare Partners's 13F filing for Q1 2024, filed 15 May 2024.